AI-generated summary
The authors conducted a retrospective review of 94 patients with hidradenitis suppurativa who received laser therapy between 2016 and 2021. They report improvement in disease severity for all patients, with no complications and minor blood loss, and conclude that laser therapy is effective and safe. The study is retrospective, with 26.0% of patients lost to follow-up.
- Participants
- 94
- Who or what was studied
- Patients with hidradenitis suppurativa undergoing laser treatment between 2016 and 2021
- Limits stated in the abstract
- The retrospective design, lack of a control group, and 26.0% loss to follow-up limit the strength of the conclusions about effectiveness and safety.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on journals.lww.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Laser. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.